Thursday, May 23, 2013 4:02 AM EST

Hepatitis B

Hepatitis B is an infectious illness caused by hepatitis B virus (HBV) which infects the liver ofhominoidea, including humans, and causes an inflammation called hepatitis. Originally known as "serum hepatitis" the disease has caused epidemics in parts of Asia and Africa, and it isendemic in China. About a third of the world's population, more than 2 billion people, have been infected with the hepatitis B virus. This includes 350 million chronic carriers of the virus. Transmission of hepatitis B virus results from exposure to infectious blood or body fluids. Read More

Headlines Around the Web

Articles About Hepatitis B

Indian Supply Drives Down Cost of Childhood Vaccine

By Reuters

The cost of immunising children in developing countries with a five-in-one vaccine is set to fall after a deal by an Indian supplier to slash the price it charges the GAVI global vaccines group. (Apr 18)

MORE TOPICS: INDIA, GLAXOSMITHKLINE, CANCER

Wall Street rallies on growth optimism

By Reuters

Stocks rose on Monday, suggesting the equity rally was intact as investors grew more confident that the global economy would continue to grow. (Feb 26)

MORE TOPICS: DOW JONES, FTSE, WHITE HOUSE, ELECTIONS, NEW JERSEY

Stock futures point to higher open, Barnes & Noble rallies

By Reuters

U.S. stock index futures pointed to a higher open on Monday, suggesting the equity rally was intact despite concerns that the Federal Reserve could curtail its stimulus for the economy sooner than many expected. (Feb 26)

MORE TOPICS: FEDERAL RESERVE, DOW JONES, WHITE HOUSE, ELECTIONS, NEW YORK

HPV vaccination
Give HPV Vaccine to Gay Men to Reduce Anal Cancer, BMA Urge

By IBTimes UK

Senior doctors ask health secretary Anna Soubry to help fight against anal cancer cases. (Jan 18)

MORE TOPICS: AUSTRALIA, INFECTION, CANCER

Seven Innovative Biotechs That Could Soar by Year-End: George Zavoico

By Street Wise Reports

Biotech has a breeze to its back, and successful progression through the phases of drug development also help propel the industry forward. In this exclusive interview with The Life Sciences Report, George Zavoico, senior analyst and managing director with MLV & Co. (Sep 14)

MORE TOPICS: NYSE, PFIZER, ADVERTISING, COPPER, MANAGEMENT, GLAXOSMITHKLINE

vaccine syringe
95 Percent of American Parents Sacrifice their Young Children to the Vaccine Industry

By Natural News

Though all 50 U.S. states recognize the natural human right of individuals to refuse otherwise compulsory vaccinations on the basis of religious, philosophical, or medical reasons -- some states recognize all three reasons as valid -- 95 percent of A... (Sep 07)

MORE TOPICS: CALIFORNIA, MEXICO, AUTISM

The number of individuals diagnosed with the dreaded Human immunodeficiency virus (HIV) has risen in Australia, prompting lawmakers and health experts to re-assess laid down national policies and programs on the disease.
Anti-HIV Pill: U.S. Gives Nod to Commercial Availability of New Drug

By IBTimes AU

A new HIV-suppressing pill gained the approval of the U.S. Federal and Drug Administration recently, paving the way for its commercial sale in the United States and possibly in other countries soon. (Aug 28)

MORE TOPICS: AIDS, INFECTION

vaccine syringe
Most U.S. Kindergartners Getting Vaccines, Risks Remain: Report

By Reuters

More than 95 percent of kindergartners were vaccinated for diphtheria, tetanus, acellular pertussis, polio and hepatitis B, meeting federal guidelines, the Centers for Disease Control and Prevention said in a new report. (Aug 25)

MORE TOPICS: AUTISM

WHO: Four Ways to Reduce Hepatitis Infections in People Who Inject Drugs

By Health Canal

WHO has identified four key actions countries can take to prevent viral hepatitis B and C among people who inject drugs. Of the estimated 16 million people who inject drugs worldwide, it is estimated that 10 million are infected with hepatitis C. An additional 1. (Jul 30)

MORE TOPICS: AIDS, INFECTION, CANCER

Discovery of New White Blood Cell Reveals Target for Better Vaccine Design

By Health Canal

Researchers in Newcastle and Singapore have identified a new type of white blood cell which activates a killing immune response to an external source - providing a new potential target for vaccines for conditions such as cancer or Hepatitis B. (Jul 30)

MORE TOPICS: CANCER